These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23490176)
41. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma. Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388 [TBL] [Abstract][Full Text] [Related]
42. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672 [TBL] [Abstract][Full Text] [Related]
43. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709 [TBL] [Abstract][Full Text] [Related]
44. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response. Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617 [TBL] [Abstract][Full Text] [Related]
45. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765 [TBL] [Abstract][Full Text] [Related]
46. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States. Berry K; Ioannou GN Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233 [TBL] [Abstract][Full Text] [Related]
47. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma. Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825 [TBL] [Abstract][Full Text] [Related]
48. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients. Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494 [TBL] [Abstract][Full Text] [Related]
49. Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation. Liu B; Teng F; Fu H; Guo WY; Shi XM; Ni ZJ; Gao XG; Ma J; Fu ZR; Ding GS BMC Gastroenterol; 2015 Oct; 15():138. PubMed ID: 26472203 [TBL] [Abstract][Full Text] [Related]
50. Up-to-seven criteria for hepatocellular carcinoma liver transplantation: a single center analysis. Lei JY; Wang WT; Yan LN World J Gastroenterol; 2013 Sep; 19(36):6077-83. PubMed ID: 24106409 [TBL] [Abstract][Full Text] [Related]
51. Identifying patients at higher risk of hepatocellular carcinoma recurrence after liver transplantation in a multicenter cohort study from Argentina. Piñero F; Marciano S; Anders M; Orozco Ganem F; Zerega A; Cagliani J; Andriani O; de Santibañes E; Gil O; Podestá LG; McCormack L; Gadano A; Silva M Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):421-7. PubMed ID: 26684693 [TBL] [Abstract][Full Text] [Related]
52. Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation. Vitale A; Ramirez Morales R; dalla Bona E; Scopelliti M; Zanus G; Neri D; d'Amico F; Gringeri E; Russo F; Burra P; Angeli P; Cillo U Transplant Proc; 2011 May; 43(4):974-6. PubMed ID: 21620029 [TBL] [Abstract][Full Text] [Related]
53. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Nemes B; Gelley F; Piros L; Zádori G; Görög D; Fehérvári I; Kóbori L; Sárváry E; Nagy P; Kiss A; Doros A Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108 [TBL] [Abstract][Full Text] [Related]
54. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. Hu Z; Zhou J; Wang H; Zhang M; Li S; Huang Y; Wu J; Li Z; Zhou L; Zheng S PLoS One; 2013; 8(4):e61620. PubMed ID: 23613886 [TBL] [Abstract][Full Text] [Related]
55. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Chan AC; Chan SC; Chok KS; Cheung TT; Chiu DW; Poon RT; Fan ST; Lo CM Liver Transpl; 2013 Apr; 19(4):411-9. PubMed ID: 23447460 [TBL] [Abstract][Full Text] [Related]
56. Liver transplantation for hepatocellular carcinoma recurrence after liver resection: why deny this chance of cure? De Carlis L; Di Sandro S; Giacomoni A; Mangoni I; Lauterio A; Mihaylov P; Cusumano C; Rampoldi A J Clin Gastroenterol; 2013 Apr; 47(4):352-8. PubMed ID: 23188072 [TBL] [Abstract][Full Text] [Related]
57. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma. Na GH; Kim EY; Hong TH; You YK; Kim DG HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857 [TBL] [Abstract][Full Text] [Related]
58. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545 [TBL] [Abstract][Full Text] [Related]
59. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related]
60. Correlation between smoking habit and surgical outcomes on viral-associated hepatocellular carcinomas. Kai K; Komukai S; Koga H; Yamaji K; Ide T; Kawaguchi A; Aishima S; Noshiro H World J Gastroenterol; 2018 Jan; 24(1):58-68. PubMed ID: 29358882 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]